Top

Published in:

01-12-2010 | Original Paper

A Dynamic Social Systems Model for Considering Structural Factors in HIV Prevention and Detection

Authors: Carl Latkin, Margaret R. Weeks, Laura Glasman, Carol Galletly, Dolores Albarracin

Published in: AIDS and Behavior | Special Issue 2/2010

Abstract

We present a model for HIV-related behaviors that emphasizes the dynamic and social nature of the structural factors that influence HIV prevention and detection. Key structural dimensions of the model include resources, science and technology, formal social control, informal social influences and control, social interconnectedness, and settings. These six dimensions can be conceptualized on macro, meso, and micro levels. Given the inherent complexity of structural factors and their interrelatedness, HIV prevention interventions may focus on different levels and dimensions. We employ a systems perspective to describe the interconnected and dynamic processes of change among social systems and their components. The topics of HIV testing and safer injection facilities (SIFs) are analyzed using this structural framework. Finally, we discuss methodological issues in the development and evaluation of structural interventions for HIV prevention and detection.

Brown A, Moodie C, Hastings G. A longitudinal study of policy effect (smoke-free legislation) on smoking norms: ITC Scotland/United Kingdom. Nicotine Tob Res. 2009;11(8):924–32.PubMed

Glass TA, McAtee MJ. Behavioral science at the crossroads in public health: extending horizons, envisioning the future. Soc Sci Med. 2006;62(7):1650–71.PubMed

McMichael AJ. Prisoners of the proximate: loosening the constraints on epidemiology in an age of change. Am J Epidemiol. 1999;149(10):887–97.PubMed

Udoh IA, Mantell JE, Sandfort T, Eighmy MA. Potential pathways to HIV/AIDS transmission in the Niger Delta of Nigeria: poverty, migration and commercial sex. AIDS Care. 2009;21(5):567–74.PubMed

Mahajan AP, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008;22(Suppl 2):S67–79.PubMed

Hunter M. The changing political economy of sex in South Africa: the significance of unemployment and inequalities to the scale of the AIDS pandemic. Soc Sci Med. 2007;64(3):689–700.PubMed

Munoz-Laboy M, Hirsch JS, Quispe-Lazaro A. Loneliness as a sexual risk factor for male Mexican migrant workers. Am J Public Health. 2009;99(5):802–10.PubMed

Blankenship KM, Friedman SR, Working S, Mantell JE. Structural interventions: concepts, challenges and opportunities for research. J Urban Health. 2006;83(1):59–72.PubMed

Sweat MD, Denison JA. Reducing HIV incidence in developing countries with structural and environmental interventions. AIDS. 1995;9(Suppl A):S251–7.PubMed

10.

Sumartojo E. Structural factors in HIV prevention: concepts, examples, and implications for research. AIDS. 2000;14(Suppl 1):S3–10.PubMed

11.

Tawil O, Verster A, O’Reilly KR. Enabling approaches for HIV/AIDS prevention: can we modify the environment and minimize the risk? AIDS. 1995;9(12):1299–306.PubMed

12.

Parker RG, Easton D, Klein CH. Structural barriers and facilitators in HIV prevention: a review of international research. AIDS. 2000;14(Suppl 1):S22–32.PubMed

13.

Blankenship KM, Bray SJ, Merson MH. Structural interventions in public health. AIDS. 2000;14(Suppl 1):S11–21.PubMed

14.

Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. J Urban Health. 2008;85(3):309–22.PubMed

15.

Connell RW. Gender and power: society, the person and sexual politics. Stanford, CA: Stanford University Press; 1987.

16.

Cohen DA, Scribner RA, Farley TA. A structural model of health behavior: a pragmatic approach to explain and influence health behaviors at the population level. Prev Med. 2000;30(2):146–54.PubMed

17.

Barnett T, Whiteside A. AIDS in the twenty-first century: disease and globalization. Basingstoke: Palgrave Macmillan; 2002.

18.

Fuller CM, Latkin CA, Borrell LA, Galea S, Ompad DC, Strathdee SA. The effect of race, neighborhood, and social network on age of initiation of injection drug use. Am J Public Health. 2005;95(4):689–95.PubMed

19.

Latkin CA, Williams CT, Wang J, Curry AD. Neighborhood social disorder as a determinant of drug injection behaviors: a structural equation modeling approach. Health Psychol. 2005;24(1):96–100.PubMed

20.

Williams CT, Latkin CA. Neighborhood socioeconomic status, personal network attributes, and use of heroin and cocaine. Am J Prev Med. 2007;32(6):203–210.

21.

Rose DN. The epidemiology of HIV infection and AIDS in east and central Harlem, NY. Mt Sinai J Med. 1992;59(6):493–7.PubMed

22.

Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural approaches to HIV prevention. Lancet. 2008;372(9640):764–75.PubMed

23.

Kim J, Pronyk P, Barnett T, Watts C. Exploring the role of economic empowerment in HIV prevention. AIDS. 2008;22(Suppl 4):S57–71.PubMed

24.

UNAIDS. Report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS; 2008.

25.

USAID’s HIV/AIDS Program in Senegal, December 2004. Geneva, Switzerland. http://www.usaid.gov/our_work/global_health/aids/Countries/africa/senegal_04.

26.

Avert. History of HIV & AIDS in South Africa. Retrieved from http://www.avert.org/history-aids-south-africa.htm; 2009.

27.

Ashby WR. Principles of the self-organizing dynamic system. J Gen Psychol. 1947;37:125–8.PubMed

28.

Ashby W. An introduction to cybernetics. London: Chapman & Hall; 1956.

29.

von Bertalanffy, L. General system theory: foundations, development, applications. New York: George Braziller; 1968 (revised ed.; 1976).

30.

Le Moigne J-L. Le constructivisme, t. 1: Les fondements. Paris: Éd. ESF; 1994.

31.

Le Moigne J-L. Le constructivisme, t. 2: Des épistémologies. Paris: Éd. ESF; 1995.

32.

Wiener N. Cybernetics: or the control and communication in the animal and the machine. Cambridge: MIT Press; 1961.

33.

Weik K. Management of organizational change among loosely coupled elements. In: Goodman P, editor. Change in organizations. San Francisco: Jossey-Bass; 1982. p. 375–408.

34.

Goldstein J. Emergence as a construct: history and issues. Emergence: Complexity and Organization. 1999;1(1):49–72.

35.

Bronfenbrenner U. Contexts of child rearing: problems and prospects. Am Psychol. 1979;34(10):844–50.

36.

McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q. 1988;15(4):351–77.PubMed

37.

Agha S, Van Rossem R. Impact of a school-based peer sexual health intervention on normative beliefs, risk perceptions, and sexual behavior of Zambian adolescents. J Adolesc Health. 2004;34(5):441–52.PubMed

38.

Cohen DA, Farley TA, Bedimo-Etame JR, Scribner R, Ward W, Kendall C, et al. Implementation of condom social marketing in Louisiana, 1993 to 1996. Am J Public Health. 1999;89(2):204–8.PubMed

39.

Mantell JE, Scheepers E, Karim QA. Introducing the female condom through the public health sector: experiences from South Africa. AIDS Care. 2000;12(5):589–601.PubMed

40.

Warren M, Philpott A. Expanding safer sex options: introducing the female condom into national programmes. Reprod Health Matters. 2003;11(21):130–9.PubMed

41.

Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ. et al. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998;113(Suppl 1):42–57.PubMed

42.

Kelly JA, St. Lawrence JS, Stevenson LY, Hauth AC, Kalichman SC, Diaz YE, et al. Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities. Am J Public Health. 1992;82(11):1483–9.PubMed

43.

Latkin CA, Sherman S, Knowlton AR. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22(4):332–9.PubMed

44.

Weeks MR, Convey M, Dickson-Gomez J, Li J, Radda K, Martinez M, et al. Changing drug users’ risk environments: peer health advocates as multi-level community change agents. Am J Community Psychol. 2009;43(3–4):330–44.PubMed

45.

Jana S, Basu I, Rotheram-Borus MJ, Newman PA. The Sonagachi Project: a sustainable community intervention program. AIDS Educ Prev. 2004;16(5):405–14.PubMed

46.

Kegeles SM, Hays RB, Pollack LM, Coates TJ. Mobilizing young gay and bisexual men for HIV prevention: a two-community study. AIDS. 1999;13(13):1753–62.PubMed

47.

Ramirez-Valles J. The protective effects of community involvement for HIV risk behavior: a conceptual framework. Health Educ Res. 2002;17(4):389–403.PubMed

48.

Dickson-Gomez J, Convey M, Hilario H, Corbett AM, Weeks M. Unofficial policy: access to housing, housing information and social services among homeless drug users in Hartford, Connecticut. Subst Abuse Treat Prev Policy. 2007;2:8.PubMed

49.

Simmel G. The web of group affiliations. In: Kurt W, editor. Conflict and the web of group affiliations. Glencoe, IL: Free Press; 1955. p. 125–95.

50.

Bandura A. Social learning theory. Englewood Cliffs, NJ: Prentice Hall; 1977.

51.

Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003.

52.

Lewis M, DeVellis B, Sleath B. Social influence and interpersonal communication in health behavior. In: Glanz K, Rimer BK, Lewis FM, editors. Health behavior and health education: theory, research, and practice. San Francisco: Jossey-Bass; 2002. p. 240–64.

53.

Terry D, Hogg M. Attitudes, behavior, and social context: the role of norms and group membership. Mahwah, NJ: Lawrence Erlbaum Associates Publishers; 2000.

54.

Turner JC. Social comparison and social identity: some perspectives for intergroup behavior. Eur J Soc Psychol. 1978;5:5–34.

55.

Giddens A. Central problems in social theory: action, structure, and contradiction in social analysis. Berkeley, CA.: University of California Press; 1979.

56.

Yang CH, Yang SY, Shen MH, Kuo HS. The changing epidemiology of prevalent diagnosed HIV infections in Taiwan, 1984–2005. Int J Drug Policy. 2008;19(4):317–23.PubMed

57.

Kroll T, Jones GC, Kehn M, Neri MT. Barriers and strategies affecting the utilisation of primary preventive services for people with physical disabilities: a qualitative inquiry. Health Soc Care Community. 2006;14(4):284–93.PubMed

58.

Wang LY, Davis M, Robin L, Collins J, Coyle K, Baumler E. Economic evaluation of safer choices: a school-based human immunodeficiency virus, other sexually transmitted diseases, and pregnancy prevention program. Arch Pediatr Adolesc Med. 2000;154(10):1017–24.PubMed

59.

Kirby D, Obasi A, Laris BA. The effectiveness of sex education and HIV education interventions in schools in developing countries. World Health Organ Tech Rep Ser. 2006;938:103–50.PubMed

60.

Siegel DM, Aten MJ, Enaharo M. Long-term effects of a middle school- and high school-based human immunodeficiency virus sexual risk prevention intervention. Arch Pediatr Adolesc Med. 2001;155(10):1117–26.PubMed

61.

Lin N, Ye X, Ensel WM. Social support and depressed mood: a structural analysis. J Health Soc Behav. 1999;40(4):344–59.PubMed

62.

Pollini RA, Brouwer KC, Lozada RM, Ramos R, Cruz MF, Magis-Rodriguez C, et al. Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities. Addiction. 2008;103(1):101–8.PubMed

63.

King R, Katuntu D, Lifshay J, Packel L, Batamwita R, Nakayiwa S, et al. Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda. AIDS Behav. 2008;12(2):232–43.PubMed

64.

Powell JE, Taylor D. Anger, depression, and anxiety following heroin withdrawal. Int J Addict. 1992;27(1):25–35.PubMed

65.

Ksobiech K. Assessing and improving needle exchange programs: gaps and problems in the literature. Harm Reduct J. 2004;1(1):4.PubMed

66.

Hedrich D. European report on drug consumption rooms. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2004.

67.

Kimber J, Dolan K. Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia. J Urban Health. 2007;84(2):255–66.PubMed

68.

Kerr T, Small W, Moore D, Wood E. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver’s safer injection facility. Int J Drug Policy. 2007;18(1):37–45.PubMed

69.

Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ. 2006;175(11):1399–404.PubMed

70.

Kerr T, Stoltz JA, Tyndall M, Li K, Zhang R, Montaner J, et al. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ. 2006;332(7535):220–2.PubMed

71.

Wood E, Tyndall MW, Qui Z, Zhang R, Montaner JS, Kerr T. Service uptake and characteristics of injection drug users utilizing North America’s first medically supervised safer injecting facility. Am J Public Health. 2006;96(5):770–3.PubMed

72.

Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366(9482):316–8.PubMed

73.

Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ. 2004;171(7):731–4.PubMed

74.

DeBeck K, Wood E, Zhang R, Tyndall M, Montaner J, Kerr T. Police and public health partnerships: evidence from the evaluation of Vancouver’s supervised injection facility. Subst Abuse Treat Prev Policy. 2008;3:11.PubMed

75.

Campsmith M, Rhodes P, Hall H, Green T. HIV Prevalence estimates—United States, 2006. Morb Mortal Wkly Rep. 2008;57:1073–6.

76.

Weinhardt LS. Changing HIV and AIDS-related behavior: promising approaches at the individual, group, and community levels. Behav Modif. 2005;29(2):219–26.PubMed

77.

Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005;40(1):96–101.PubMed

78.

Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57.PubMed

79.

Burke RC, Sepkowitz KA, Bernstein KT, Karpati AM, Myers JE, Tsoi BW, et al. Why don’t physicians test for HIV? A review of the US literature. AIDS. 2007;21(12):1617–24.PubMed

80.

Greenwald JL, Hall J, Skolnik PR. Approaching the CDC’s guidelines on the HIV testing of inpatients: physician-referral versus nonreferral-based testing. AIDS Patient Care STDS. 2006;20(5):311–7.PubMed

81.

Prost A, Chopin M, McOwan A, Elam G, Dodds J, Macdonald N, et al. “There is such a thing as asking for trouble”: taking rapid HIV testing to gay venues is fraught with challenges. Sex Transm Infect. 2007;83(3):185–8.PubMed

82.

White DA, Scribner AN, Schulden JD, Branson BM, Heffelfinger JD. Results of a rapid HIV screening and diagnostic testing program in an urban emergency department. Ann Emerg Med. 2009;54(1):56–64.PubMed

83.

Leibowitz AA, Taylor SL. Distance to public test sites and HIV testing. Med Care Res Rev. 2007;64(5):568–84.PubMed

84.

Newhouse J. Rand Corporation Insurance Experiment Group. Free for all?: lessons from the RAND health insurance experiment. Cambridge, MA: Harvard University Press; 1993.

85.

Rosenstock IM. The health belief model and HIV risk behavior change. In: DiClemente R, Peterson J, editors. Preventing AIDS: theories and methods of behavioral interventions. AIDS prevention and mental health. New York, NY: Plenum Press; 1994. p. 5–24.

86.

Taylor SL, Leibowitz A, Simon PA, Grusky O. ZIP code correlates of HIV-testing: a multi-level analysis in Los Angeles. AIDS Behav. 2006;10(5):579–86.PubMed

87.

Maman S, Abler L, Parker L, Lane T, Chirowodza A, Ntogwisangu J, et al. A comparison of HIV stigma and discrimination in five international sites: the influence of care and treatment resources in high prevalence settings. Soc Sci Med. 2009;68(12):2271–8.PubMed

88.

Petroll AE, DiFranceisco W, McAuliffe TL, Seal DW, Kelly JA, Pinkerton SD. HIV testing rates, testing locations, and healthcare utilization among urban African-American men. J Urban Health. 2009;86(1):119–31.PubMed

89.

Latkin CA, Kuramoto SJ, Davey-Rothwell MA, Tobin KE. Social norms, social networks, and HIV risk behavior among injection drug users. AIDS Behav. 2009. doi:10.1007/s10461-009-9576-4.

90.

Heffelfinger JD, Sullivan PS, Branson BM, Mastro TD, Purcell DW, Griffiths SD, et al. Advancing HIV prevention demonstration projects: new strategies for a changing epidemic. Public Health Rep. 2008;123(Suppl 3):5–15.PubMed

91.

Kimbrough LW, Fisher HE, Jones KT, Johnson W, Thadiparthi S, Dooley S. Accessing social networks with high rates of undiagnosed HIV infection: the social networks demonstration project. Am J Public Health. 2009;99(6):1093–9.PubMed

92.

Vargo S, Agronick G, O’Donnell L, Stueve A. Using peer recruitment and OraSure to increase HIV testing. Am J Public Health. 2004;94(1):29–31.PubMed

93.

Kerr T, Kimber J, Rhodes T. Drug use settings: an emerging focus for research and intervention. Int J Drug Policy. 2007;18(1):1–4.PubMed

94.

Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1–17.PubMed

95.

Fincher-Mergi M, Cartone KJ, Mischler J, Pasieka P, Lerner EB, Billittier AJ. Assessment of emergency department health care professionals’ behaviors regarding HIV testing and referral for patients with STDs. AIDS Patient Care STDS. 2002;16(11):549–53.PubMed

96.

Galletly CL, Pinkerton SD. Preventing HIV transmission via HIV exposure laws: applying logic and mathematical modeling to compare statutory approaches to penalizing undisclosed exposure to HIV. J Law Med Ethics. 2008;36(3):577–84.PubMed

97.

Banerjee AV, Duflo E. Mandated empowerment: handing antipoverty policy back to the poor? Ann N Y Acad Sci. 2008;1136:333–41.PubMed

98.

Karnani A. Microfinance misses its mark. Stanford: Stanford Social Innovation Review Stanford Graduate School of Business; 2007.

99.

Friedman SR, Lieb S, Tempalski B, Cooper H, Keem M, Friedman R, et al. HIV among injection drug users in large US metropolitan areas, 1998. J Urban Health. 2005;82(3):434–45.PubMed

100.

Bonell C, Hargreaves J, Strange V, Pronyk P, Porter J. Should structural interventions be evaluated using RCTs? The case of HIV prevention. Soc Sci Med. 2006;63(5):1135–42.PubMed

101.

Susser M. The tribulations of trials—intervention in communities. Am J Public Health. 1995;85(2):156–8.PubMed

102.

Manhart LE, Holmes KK. Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? J Infect Dis. 2005;191(Suppl 1):S7–24.PubMed

103.

Sanson-Fisher RW, Bonevski B, Green LW, D’Este C. Limitations of the randomized controlled trial in evaluating population-based health interventions. Am J Prev Med. 2007;33(2):155–61.PubMed

104.

Diclemente RJ, Salazar LF, Crosby RA. A review of STD/HIV preventive interventions for adolescents: sustaining effects using an ecological approach. J Pediatr Psychol. 2007;32(8):888–906.PubMed

105.

Sorensen G, Emmons K, Hunt MK, Johnston D. Implications of the results of community intervention trials. Annu Rev Public Health. 1998;19:379–416.PubMed

106.

Fortmann SP, Flora JA, Winkleby MA, Schooler C, Taylor CB, Farquhar JW. Community intervention trials: reflections on the Stanford Five-City Project Experience. Am J Epidemiol. 1995;142(6):576–86.PubMed

107.

Victora CG, Habicht JP, Bryce J. Evidence-based public health: moving beyond randomized trials. Am J Public Health. 2004;94(3):400–5.PubMed

108.

West SG, Duan N, Pequegnat W, Gaist P, Des J, Holtgrave D, et al. Alternatives to the randomized controlled trial. Am J Public Health. 2008;98(8):1359–66.PubMed

109.

Hawkins NG, Sanson-Fisher RW, Shakeshaft A, D’Este C, Green LW. The multiple baseline design for evaluating population-based research. Am J Prev Med. 2007;33(2):162–8.PubMed

110.

Rapkin BD, Trickett EJ. Comprehensive dynamic trial designs for behavioral prevention research with communities: overcoming inadequacies of the randomized controlled trial paradigm. In: Trickett EJ, Pequegnat W, editors. Community interventions and AIDS. New York, NY: Oxford University Press; 2005.

111.

Bernard HR. Social research methods: qualitative and quantitative approaches. Thousand Oaks, CA: Sage Publications; 2000.

112.

LeCompte MD, Schensul JJ. Analyzing & interpreting ethnographic data: ethnographer’s toolkit, vol. 5. Walnut Creek, CA: AltaMira Press; 1999.

113.

Miles MB, Huberman AM. Qualitative data analysis: an expanded sourcebook. 2nd ed. Thousands Oaks, CA: Sage Publications; 1994.

114.

Ragin CC. The comparative method: moving beyond qualitative and quantitative strategies. Berkeley, CA: University of California Press; 1987.

115.

Green LW. From research to “best practices” in other settings and populations. Am J Health Behav. 2001;25(3):165–77.PubMed

116.

Flay BR. Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs. Prev Med. 1986;15:451–4.PubMed

Title: A Dynamic Social Systems Model for Considering Structural Factors in HIV Prevention and Detection
Authors: Carl Latkin
Margaret R. Weeks
Laura Glasman
Carol Galletly
Dolores Albarracin
Publication date: 01-12-2010
Publisher: Springer US
Published in: AIDS and Behavior / Issue Special Issue 2/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-010-9804-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2010

Wanted: A Theoretical Roadmap to Research and Practice Across Individual, Interpersonal, and Structural Levels of Analysis

A Network-Individual-Resource Model for HIV Prevention

Modeling Structural, Dyadic, and Individual Factors: The Inclusion and Exclusion Model of HIV Related Behavior

A Framework for Incorporating Dyads in Models of HIV-Prevention

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials